Numbers

Claude View

The Numbers

MAHLIFE trades at 2.0x book and 25.6x earnings on a reported ROE of 2.2% and ROCE of 2.2% – ratios that make no sense until you understand that the real earnings engine (JV/associate income of ~₹186 Cr/year) sits below the operating line, and the balance sheet carries ₹3,423 Cr of equity inflated by a recent rights issue that has not yet been deployed. The single metric most likely to rerate or derate this stock is quarterly pre-sales run-rate vs the implied FY30 slope: anything above ₹900 Cr/quarter confirms the 28% CAGR thesis; anything below ₹700 Cr for two consecutive quarters kills it.

Revenue and Earnings – The Accounting Mirage

Reported revenue is meaningless for MAHLIFE as a standalone metric. IND-AS 115 project-completion accounting means revenue recognition lags pre-sales by 3-5 years. The real earnings flow through "Share of JV/Associate Profit" – ₹186 Cr in FY25 and ₹167 Cr in 9MFY26 – which dwarfs standalone operating income (which has been negative every year since FY22).

Revenue has never sustainably exceeded ₹600 Cr since FY15 (₹1,086 Cr, the all-time peak). Net income has been marginally positive or negative in most years, masked by large swings in JV income and one-time items. FY20-FY21 saw cumulative losses of ₹266 Cr during the Covid trough.

Pre-sales – The Only Revenue Line That Matters

For a developer with project-completion accounting, pre-sales are the leading indicator of everything. MAHLIFE has compounded pre-sales at ~32% CAGR from FY21 to FY25, but still needs ~28% CAGR for 5 more years to hit the ₹9,500-10,000 Cr FY30 target.

Management guides 20%+ project IRRs with PBT margins of ~19-20%. The mix is shifting decisively toward premium post-FY23 projects (71% of FY25 value, expected 97% by FY30), which carry higher ticket sizes (₹1.5-5 Cr) and less rate sensitivity.

Cash Generation – The Structural Negative

MAHLIFE is a cash-consuming machine at this stage of its growth. Operating cash flow has been negative in 8 of the last 12 years because cash goes into land acquisition and project development before revenue recognition catches up.

FY24-FY25 show the new pattern: massive operating cash outflows (₹661 Cr, ₹542 Cr) funded by financing inflows (₹489 Cr, ₹416 Cr) – including the ₹1,500 Cr rights issue. This is the hallmark of a developer in aggressive land-accumulation phase.

Management's own cash flow disclosure (non-GAAP) shows positive operating cash flow of ₹558 Cr in 9MFY26 (project inflows minus outflows), before land acquisition spend of ₹802 Cr. The business generates cash from operations; it is the land acquisition strategy that turns the consolidated number negative.

Balance Sheet – Fortress After the Rights Issue

The Q1FY26 rights issue (₹1,500 Cr, equity capital went from ₹155 Cr to ₹213 Cr – approximately 37% dilution in shares outstanding) transformed the balance sheet. Net debt/equity went from 0.39 in FY25 to -0.12 by Q3FY26 (net cash). Gross debt collapsed from ₹1,439 Cr (FY25) to ₹325 Cr (Q2FY26). Cost of debt fell from 8.6% (FY24) to 6.7% (Q3FY26).

Working Capital – The Cycle Signal

Debtor days at 136 (FY25) remain elevated above the 80-day "normal" range, though improved from the 184-day FY24 spike. Working capital days of 1,237 reflect the massive inventory build (land bank expansion). History shows debtor days above 120 have always preceded multi-year recovery lags.

ROCE – The Structural Challenge

ROCE has not exceeded 7% since FY15. The current 2% is an artifact of: (a) a bloated equity base post-rights-issue, (b) JV/associate income not captured in the ROCE numerator at the operating level, and (c) the land-banking phase consuming capital without yet generating returns. Management targets 18-20% project IRRs at launch, but this has not yet translated into consolidated return metrics.

Shareholding – Stable Promoter, FII Exodus

Two trends stand out: (1) Promoter holding stepped up from 51.1% to 52.4% via the rights issue – Mahindra Group put its money where its mouth is. (2) FII holding has steadily declined from 11.9% (Sep 23) to 7.8% (Dec 25) – foreign investors are not yet buying the growth story. DIIs have been absorbing the selling.

IC&IC Land Bank – The Hidden Cash Cow

Total 5,737 gross acres, 2,352 net leased, 1,634 available. Management guides ₹5,000-6,000 Cr revenue and ~₹1,500 Cr PAT over the next ~10 years from this land bank. At FY25 run-rate of ~111 acres/year leased, the remaining bank lasts ~14 years. Realisation per acre has risen from ₹2.6 Cr (FY20) to ₹4.2 Cr (FY25) at MWC Chennai.

Peer Comparison – The Scale Gap

MAHLIFE is the smallest player on both axes – lowest pre-sales and lowest ROCE. It trades at the cheapest P/B (2.03x) in the peer set, but that low multiple is earned: no other peer has a 2% ROCE. Oberoi (17.7% ROCE on 5,281 Cr pre-sales) and Lodha (15.6% ROCE on 17,630 Cr) are the gold standard for what scale plus capital efficiency looks like.

Earnings Quality – Where the Real Profit Lives

For four consecutive years, operating income has been deeply negative (₹-88 to ₹-171 Cr) while "other income" (dominated by JV/associate profit share) has been ₹200-277 Cr. The entire P&L is propped up by associate income. This is not a red flag – it is structural to the JV-heavy development model – but it makes traditional earnings multiples unreliable.

The Critical Chart – Pre-sales vs Market Expectation

What the Numbers Confirm, Contradict, and Demand

Confirmed: The balance sheet is the strongest it has ever been (net cash, 6.7% cost of debt, 52.4% promoter holding). The GDV pipeline at ₹46,770 Cr is 16x current pre-sales – ample runway. Q3FY26 shows the first real P&L inflection in six years.

Contradicted: The reported ROE (2.2%) and ROCE (2.2%) flatly contradict the valuation – you cannot justify 2x book on a 2% return unless you believe returns will ramp dramatically. Operating cash flow is structurally negative and will remain so while the land-banking phase continues. FII selling (11.9% to 7.8% over two years) suggests institutional skepticism.

Watch next quarter: Q4FY26 pre-sales must be ₹800+ Cr to keep the FY26 number above ₹3,000 Cr. Bhandup approval status is binary – ₹12,400 Cr of GDV (27% of pipeline) hinges on Mumbai regulatory clearance. Origins Pune and Origins Ahmedabad first lease signings would de-risk the IC&IC harvest curve.